$PRTK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Paratek Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Paratek Pharmaceuticals, Inc.. Get notifications about new insider transactions in Paratek Pharmaceuticals, Inc. for free.
Page: < prev 1 2 3 4 5 6 7 ... 9 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Option Exercise | D | 56.88 | 1,666 | 94,762 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Option Exercise | D | 41.16 | 2,083 | 85,736 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Grant | A | 0.00 | 5,430 | 0 | 5,430 | 0 to 5.4 K |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | KILEY THOMAS | Director | Option Exercise | D | 48.84 | 1,125 | 54,945 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | KILEY THOMAS | Director | Option Exercise | D | 82.20 | 583 | 47,923 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | KILEY THOMAS | Director | Option Exercise | D | 90.24 | 583 | 52,610 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | KILEY THOMAS | Director | Option Exercise | D | 80.88 | 158 | 12,779 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | KILEY THOMAS | Director | Option Exercise | D | 82.56 | 333 | 27,492 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | KILEY THOMAS | Director | Option Exercise | D | 38.04 | 833 | 31,687 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | LOAR MATTHEW M | Director | Option Exercise | D | 23.64 | 2,083 | 49,242 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Ruegsegger Frederick J | Director | Option Exercise | D | 48.84 | 1,125 | 54,945 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Ruegsegger Frederick J | Director | Option Exercise | D | 82.20 | 583 | 47,923 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Ruegsegger Frederick J | Director | Option Exercise | D | 90.24 | 583 | 52,610 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Ruegsegger Frederick J | Director | Option Exercise | D | 80.88 | 158 | 12,779 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Ruegsegger Frederick J | Director | Option Exercise | D | 82.56 | 333 | 27,492 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Ruegsegger Frederick J | Director | Option Exercise | D | 33.72 | 333 | 11,229 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Ruegsegger Frederick J | Director | Option Exercise | D | 152.04 | 833 | 126,649 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | RAAB G KIRK | Director | Option Exercise | D | 48.84 | 5,208 | 254,359 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | RAAB G KIRK | Director | Option Exercise | D | 81.12 | 3,750 | 304,200 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | RAAB G KIRK | Director | Option Exercise | D | 82.44 | 3,166 | 261,005 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | RAAB G KIRK | Director | Option Exercise | D | 80.88 | 1,458 | 117,923 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | RAAB G KIRK | Director | Option Exercise | D | 82.56 | 416 | 34,345 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | RAAB G KIRK | Director | Option Exercise | D | 38.04 | 1,666 | 63,375 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Singh Nikhilesh N | SVP & Chief Scienti ... | Option Exercise | D | 19.20 | 9,583 | 183,994 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Singh Nikhilesh N | SVP & Chief Scienti ... | Option Exercise | D | 48.84 | 10,000 | 488,400 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Singh Nikhilesh N | SVP & Chief Scienti ... | Option Exercise | D | 81.12 | 5,000 | 405,600 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Singh Nikhilesh N | SVP & Chief Scienti ... | Option Exercise | D | 16.20 | 6,458 | 104,620 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Singh Nikhilesh N | SVP & Chief Scienti ... | Option Exercise | D | 82.44 | 4,833 | 398,433 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Singh Nikhilesh N | SVP & Chief Scienti ... | Option Exercise | D | 82.56 | 5,950 | 491,232 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Singh Nikhilesh N | SVP & Chief Scienti ... | Option Exercise | D | 33.72 | 3,500 | 118,020 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Singh Nikhilesh N | SVP & Chief Scienti ... | Option Exercise | D | 5.61 | 16,791 | 94,198 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Singh Nikhilesh N | SVP & Chief Scienti ... | Grant | A | 21.59 | 11,758 | 253,832 | 12,147 | 389 to 12.1 K (+3,022.62 %) |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | PATTERSON LEONE D | Vice President, CFO | Option Exercise | D | 19.20 | 9,583 | 183,994 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | PATTERSON LEONE D | Vice President, CFO | Option Exercise | D | 48.84 | 6,666 | 325,567 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | PATTERSON LEONE D | Vice President, CFO | Option Exercise | D | 56.64 | 7,500 | 424,800 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | PATTERSON LEONE D | Vice President, CFO | Grant | A | 21.59 | 4,161 | 89,828 | 4,161 | 0 to 4.2 K |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Kollins John A | SVP, Chief Business ... | Option Exercise | D | 19.20 | 9,583 | 183,994 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Kollins John A | SVP, Chief Business ... | Option Exercise | D | 48.84 | 7,500 | 366,300 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Kollins John A | SVP, Chief Business ... | Option Exercise | D | 57.36 | 7,083 | 406,281 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Kollins John A | SVP, Chief Business ... | Option Exercise | D | 81.12 | 4,166 | 337,946 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Kollins John A | SVP, Chief Business ... | Grant | A | 21.59 | 4,161 | 89,828 | 4,161 | 0 to 4.2 K |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | OCLASSEN GLENN A | President and CEO | Option Exercise | D | 19.20 | 18,750 | 360,000 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | OCLASSEN GLENN A | President and CEO | Option Exercise | D | 48.84 | 20,833 | 1,017,484 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | OCLASSEN GLENN A | President and CEO | Option Exercise | D | 81.12 | 15,000 | 1,216,800 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | OCLASSEN GLENN A | President and CEO | Option Exercise | D | 16.20 | 12,916 | 209,239 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | OCLASSEN GLENN A | President and CEO | Option Exercise | D | 82.44 | 12,666 | 1,044,185 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | OCLASSEN GLENN A | President and CEO | Option Exercise | D | 82.56 | 14,233 | 1,175,076 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | OCLASSEN GLENN A | President and CEO | Option Exercise | D | 33.72 | 7,500 | 252,900 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | OCLASSEN GLENN A | President and CEO | Option Exercise | D | 5.61 | 8,655 | 48,555 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | OCLASSEN GLENN A | President and CEO | Grant | A | 21.59 | 10,613 | 229,113 | 36,513 | 25.9 K to 36.5 K (+40.98 %) |
Nov 03 2014 | PRTK | Paratek Pharmaceut ... | Lim Richard J. | Director | Option Exercise | J | 0.15 | 4,083 | 612 | 4,083 | |
Nov 03 2014 | PRTK | Paratek Pharmaceut ... | Lim Richard J. | Director | Option Exercise | J | 0.15 | 2,329 | 349 | 2,329 | |
Nov 03 2014 | PRTK | Paratek Pharmaceut ... | Lim Richard J. | Director | Buy | J | 0.00 | 1,110,442 | 0 | 1,110,442 | 0 to 1.1 M |
Nov 03 2014 | PRTK | Paratek Pharmaceut ... | Lim Richard J. | Director | Buy | J | 0.00 | 395,187 | 0 | 395,187 | 0 to 395.2 K |
Nov 03 2014 | PRTK | Paratek Pharmaceut ... | Lim Richard J. | Director | Buy | J | 0.00 | 633,243 | 0 | 633,243 | 0 to 633.2 K |
Nov 03 2014 | PRTK | Paratek Pharmaceut ... | Loh Evan | See Remarks | Option Exercise | J | 4.30 | 78,957 | 339,515 | 236,871 | |
Nov 03 2014 | PRTK | Paratek Pharmaceut ... | Loh Evan | See Remarks | Option Exercise | J | 4.30 | 78,957 | 339,515 | 157,914 | |
Nov 03 2014 | PRTK | Paratek Pharmaceut ... | Loh Evan | See Remarks | Option Exercise | J | 4.30 | 78,957 | 339,515 | 78,957 | |
Nov 03 2014 | PRTK | Paratek Pharmaceut ... | Loh Evan | See Remarks | Buy | J | 0.00 | 44,389 | 0 | 44,389 | 0 to 44.4 K |
Nov 03 2014 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Option Exercise | J | 4.30 | 145,093 | 623,900 | 435,279 | |
Nov 03 2014 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Option Exercise | J | 4.30 | 145,093 | 623,900 | 290,186 | |
Nov 03 2014 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Option Exercise | J | 4.30 | 145,093 | 623,900 | 145,093 | |
Nov 03 2014 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Buy | J | 0.00 | 1,301,413 | 0 | 1,301,413 | 0 to 1.3 M |
Nov 03 2014 | PRTK | Paratek Pharmaceut ... | Boxmeyer Kathryn M. | See Remarks | Option Exercise | J | 4.30 | 6,272 | 26,970 | 6,272 | |
Nov 03 2014 | PRTK | Paratek Pharmaceut ... | Boxmeyer Kathryn M. | See Remarks | Buy | J | 0.00 | 45 | 0 | 45 | 0 to 45 |
Nov 03 2014 | PRTK | Paratek Pharmaceut ... | Boxmeyer Kathryn M. | See Remarks | Buy | J | 0.00 | 50,817 | 0 | 50,817 | 0 to 50.8 K |
Dec 17 2013 | PRTK | Paratek Pharmaceut ... | LOAR MATTHEW M | Director | Option Exercise | A | 3.30 | 25,000 | 82,500 | 25,000 | |
Dec 17 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | S | 3.54 | 1,470 | 5,204 | 1,883,021 | 1.9 M to 1.9 M (-0.08 %) |
Dec 12 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | S | 3.57 | 500 | 1,786 | 1,884,491 | 1.9 M to 1.9 M (-0.03 %) |
Dec 12 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | S | 3.53 | 520 | 1,836 | 1,884,991 | 1.9 M to 1.9 M (-0.03 %) |
Dec 12 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | S | 3.55 | 9,470 | 33,654 | 1,885,511 | 1.9 M to 1.9 M (-0.50 %) |
Dec 10 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | J | 0.00 | 2,030 | 0 | 1,894,951 | 1.9 M to 1.9 M (-0.11 %) |
Dec 10 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | S | 3.54 | 8,710 | 30,839 | 1,896,981 | 1.9 M to 1.9 M (-0.46 %) |
Dec 05 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | S | 3.50 | 5,450 | 19,075 | 1,905,691 | 1.9 M to 1.9 M (-0.29 %) |
Dec 05 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | S | 3.50 | 1,670 | 5,845 | 1,911,141 | 1.9 M to 1.9 M (-0.09 %) |
Nov 27 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | J | 0.00 | 1,800 | 0 | 1,912,811 | 1.9 M to 1.9 M (-0.09 %) |
Nov 27 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | J | 0.00 | 1,840 | 0 | 1,914,611 | 1.9 M to 1.9 M (-0.10 %) |
Nov 25 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | J | 0.00 | 1,780 | 0 | 1,916,451 | 1.9 M to 1.9 M (-0.09 %) |
Nov 25 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | J | 0.00 | 3,960 | 0 | 1,918,231 | 1.9 M to 1.9 M (-0.21 %) |
Nov 20 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | S | 3.61 | 1,540 | 5,559 | 1,922,191 | 1.9 M to 1.9 M (-0.08 %) |
Nov 20 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | S | 3.55 | 3,060 | 10,863 | 1,923,731 | 1.9 M to 1.9 M (-0.16 %) |
Nov 20 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | S | 3.57 | 5,440 | 19,426 | 1,926,791 | 1.9 M to 1.9 M (-0.28 %) |
Nov 13 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | S | 3.51 | 1,780 | 6,248 | 1,932,231 | 1.9 M to 1.9 M (-0.09 %) |
Nov 13 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | S | 3.50 | 1,780 | 6,230 | 1,934,011 | 1.9 M to 1.9 M (-0.09 %) |
Nov 13 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | S | 3.56 | 3,630 | 12,923 | 1,935,791 | 1.9 M to 1.9 M (-0.19 %) |
Nov 06 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | J | 0.00 | 1,830 | 0 | 1,939,421 | 1.9 M to 1.9 M (-0.09 %) |
Nov 06 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | J | 0.00 | 3,120 | 0 | 1,941,251 | 1.9 M to 1.9 M (-0.16 %) |
Nov 06 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | J | 0.00 | 2,580 | 0 | 1,944,371 | 1.9 M to 1.9 M (-0.13 %) |
Nov 06 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | J | 0.00 | 2,880 | 0 | 1,946,951 | 1.9 M to 1.9 M (-0.15 %) |
Nov 06 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | S | 3.75 | 2,380 | 8,925 | 1,949,831 | 2 M to 1.9 M (-0.12 %) |
Oct 30 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | S | 3.85 | 550 | 2,118 | 1,952,211 | 2 M to 2 M (-0.03 %) |
Oct 30 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | S | 3.75 | 1,070 | 4,013 | 1,952,761 | 2 M to 2 M (-0.05 %) |
Oct 30 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | S | 3.66 | 3,230 | 11,830 | 1,953,831 | 2 M to 2 M (-0.17 %) |
Oct 30 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | S | 3.66 | 2,170 | 7,935 | 1,957,061 | 2 M to 2 M (-0.11 %) |
Oct 10 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | S | 3.60 | 750 | 2,702 | 1,959,231 | 2 M to 2 M (-0.04 %) |
Sep 27 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | S | 3.69 | 4,800 | 17,714 | 1,959,981 | 2 M to 2 M (-0.24 %) |
Sep 27 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | S | 3.70 | 1,910 | 7,067 | 1,964,781 | 2 M to 2 M (-0.10 %) |
Sep 19 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | J | 0.00 | 2,730 | 0 | 1,966,691 | 2 M to 2 M (-0.14 %) |
Sep 13 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | J | 0.00 | 1,910 | 0 | 1,969,421 | 2 M to 2 M (-0.10 %) |
Sep 10 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | J | 0.00 | 14,070 | 0 | 1,971,331 | 2 M to 2 M (-0.71 %) |
Sep 10 2013 | PRTK | Paratek Pharmaceut ... | Roumell Asset Management, LLC | 10% Owner | Sell | J | 0.00 | 1,830 | 0 | 1,985,401 | 2 M to 2 M (-0.09 %) |
Jul 18 2013 | PRTK | Paratek Pharmaceut ... | OCLASSEN GLENN A | President and CEO | Option Exercise | A | 2.93 | 225,000 | 659,250 | 225,000 | |
Jul 18 2013 | PRTK | Paratek Pharmaceut ... | Soloway Thomas P | EVP, Chief Operatin ... | Option Exercise | A | 2.93 | 115,000 | 336,950 | 115,000 | |
Jul 18 2013 | PRTK | Paratek Pharmaceut ... | Singh Nikhilesh N | SVP & Chief Scienti ... | Option Exercise | A | 2.93 | 115,000 | 336,950 | 115,000 | |
Jul 18 2013 | PRTK | Paratek Pharmaceut ... | Kollins John A | SVP, Chief Business ... | Option Exercise | A | 2.93 | 115,000 | 336,950 | 115,000 | |
Jul 18 2013 | PRTK | Paratek Pharmaceut ... | PATTERSON LEONE D | Vice President, CFO | Option Exercise | A | 2.93 | 115,000 | 336,950 | 115,000 | |
Apr 11 2013 | PRTK | Paratek Pharmaceut ... | Ehrlich Christopher B | Director | Option Exercise | A | 4.76 | 13,500 | 64,260 | 13,500 | |
Apr 11 2013 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Option Exercise | A | 4.76 | 25,000 | 119,000 | 25,000 | |
Jan 09 2013 | PRTK | Paratek Pharmaceut ... | Nunn Jason Raleigh | Director | Option Exercise | A | 5.40 | 13,500 | 72,900 | 13,500 | |
Jan 08 2013 | PRTK | Paratek Pharmaceut ... | Singh Nikhilesh N | SVP & Chief Scienti ... | Option Exercise | A | 5.40 | 120,000 | 648,000 | 120,000 | |
Jan 08 2013 | PRTK | Paratek Pharmaceut ... | Ehrlich Christopher B | Director | Option Exercise | A | 5.40 | 13,500 | 72,900 | 13,500 | |
Jan 08 2013 | PRTK | Paratek Pharmaceut ... | Ruegsegger Frederick J | Director | Option Exercise | A | 5.40 | 13,500 | 72,900 | 13,500 | |
Jan 08 2013 | PRTK | Paratek Pharmaceut ... | KILEY THOMAS | Director | Option Exercise | A | 5.40 | 13,500 | 72,900 | 13,500 | |
Jan 08 2013 | PRTK | Paratek Pharmaceut ... | RAAB G KIRK | Director | Option Exercise | A | 5.40 | 62,500 | 337,500 | 62,500 | |
Jan 08 2013 | PRTK | Paratek Pharmaceut ... | OCLASSEN GLENN A | President and CEO | Option Exercise | A | 5.40 | 250,000 | 1,350,000 | 250,000 | |
Jan 08 2013 | PRTK | Paratek Pharmaceut ... | Kollins John A | SVP, Chief Business ... | Option Exercise | A | 5.40 | 90,000 | 486,000 | 90,000 | |
Jan 08 2013 | PRTK | Paratek Pharmaceut ... | Soloway Thomas P | EVP, Chief Operatin ... | Option Exercise | A | 5.40 | 140,000 | 756,000 | 140,000 | |
Jan 08 2013 | PRTK | Paratek Pharmaceut ... | PATTERSON LEONE D | Vice President, CFO | Option Exercise | A | 5.40 | 80,000 | 432,000 | 80,000 | |
Jun 26 2012 | PRTK | Paratek Pharmaceut ... | PATTERSON LEONE D | Vice President, CFO | Option Exercise | A | 6.05 | 90,000 | 544,500 | 90,000 | |
Jun 21 2012 | PRTK | Paratek Pharmaceut ... | Kollins John A | SVP, Chief Business ... | Option Exercise | A | 6.11 | 85,000 | 519,350 | 85,000 | |
Apr 17 2012 | PRTK | Paratek Pharmaceut ... | WORTZMAN MARILYN E | VP, Finance | Option Exercise | M | 2.12 | 4,600 | 9,764 | 481 | |
Apr 17 2012 | PRTK | Paratek Pharmaceut ... | WORTZMAN MARILYN E | VP, Finance | Sell | S | 11.40 | 4,600 | 52,440 | 217 | 4.8 K to 217 (-95.50 %) |
Apr 17 2012 | PRTK | Paratek Pharmaceut ... | WORTZMAN MARILYN E | VP, Finance | Buy | M | 2.12 | 4,600 | 9,764 | 4,817 | 217 to 4.8 K (+2,119.82 %) |
Mar 20 2012 | PRTK | Paratek Pharmaceut ... | WORTZMAN MARILYN E | VP, Finance | Option Exercise | M | 4.14 | 4,600 | 19,044 | 15,400 | |
Mar 20 2012 | PRTK | Paratek Pharmaceut ... | WORTZMAN MARILYN E | VP, Finance | Option Exercise | M | 2.12 | 573 | 1,216 | 5,081 | |
Mar 20 2012 | PRTK | Paratek Pharmaceut ... | WORTZMAN MARILYN E | VP, Finance | Option Exercise | M | 1.77 | 4,027 | 7,123 | 0 | |
Mar 20 2012 | PRTK | Paratek Pharmaceut ... | WORTZMAN MARILYN E | VP, Finance | Sell | S | 10.00 | 4,600 | 46,000 | 217 | 4.8 K to 217 (-95.50 %) |
Mar 20 2012 | PRTK | Paratek Pharmaceut ... | WORTZMAN MARILYN E | VP, Finance | Buy | M | 4.14 | 4,600 | 19,044 | 4,817 | 217 to 4.8 K (+2,119.82 %) |
Mar 20 2012 | PRTK | Paratek Pharmaceut ... | WORTZMAN MARILYN E | VP, Finance | Sell | S | 10.00 | 573 | 5,730 | 217 | 790 to 217 (-72.53 %) |
Mar 20 2012 | PRTK | Paratek Pharmaceut ... | WORTZMAN MARILYN E | VP, Finance | Buy | M | 2.12 | 573 | 1,216 | 790 | 217 to 790 (+264.06 %) |
Mar 20 2012 | PRTK | Paratek Pharmaceut ... | WORTZMAN MARILYN E | VP, Finance | Sell | S | 10.00 | 4,027 | 40,270 | 217 | 4.2 K to 217 (-94.89 %) |
Mar 20 2012 | PRTK | Paratek Pharmaceut ... | WORTZMAN MARILYN E | VP, Finance | Buy | M | 1.77 | 4,027 | 7,123 | 4,244 | 217 to 4.2 K (+1,855.76 %) |
Feb 03 2012 | PRTK | Paratek Pharmaceut ... | RAAB G KIRK | Director | Option Exercise | A | 8.09 | 45,000 | 364,050 | 45,000 | |
Feb 02 2012 | PRTK | Paratek Pharmaceut ... | OCLASSEN GLENN A | President and CEO | Option Exercise | A | 8.09 | 180,000 | 1,456,200 | 180,000 | |
Feb 02 2012 | PRTK | Paratek Pharmaceut ... | Soloway Thomas P | SVP, Operations and ... | Option Exercise | A | 8.09 | 60,000 | 485,400 | 60,000 | |
Feb 02 2012 | PRTK | Paratek Pharmaceut ... | Singh Nikhilesh N | SVP & Chief Scienti ... | Option Exercise | A | 8.09 | 60,000 | 485,400 | 60,000 | |
Feb 02 2012 | PRTK | Paratek Pharmaceut ... | WORTZMAN MARILYN E | VP, Finance | Option Exercise | A | 8.09 | 30,000 | 242,700 | 30,000 | |
Jan 26 2012 | PRTK | Paratek Pharmaceut ... | LAPORTE KATHLEEN | Director | Option Exercise | A | 8.18 | 7,000 | 57,260 | 7,000 | |
Jan 26 2012 | PRTK | Paratek Pharmaceut ... | Nunn Jason Raleigh | Director | Option Exercise | A | 8.18 | 7,000 | 57,260 | 7,000 | |
Jan 25 2012 | PRTK | Paratek Pharmaceut ... | Ehrlich Christopher B | Director | Option Exercise | A | 8.18 | 7,000 | 57,260 | 7,000 | |
Jan 25 2012 | PRTK | Paratek Pharmaceut ... | KILEY THOMAS | Director | Option Exercise | A | 8.18 | 7,000 | 57,260 | 7,000 | |
Jan 25 2012 | PRTK | Paratek Pharmaceut ... | Ruegsegger Frederick J | Director | Option Exercise | A | 8.18 | 7,000 | 57,260 | 7,000 | |
Dec 29 2011 | PRTK | Paratek Pharmaceut ... | KILEY THOMAS | Director | Gift | G | 0.00 | 3,200 | 0 | 67,169 | 70.4 K to 67.2 K (-4.55 %) |
Dec 05 2011 | PRTK | Paratek Pharmaceut ... | Singh Nikhilesh N | SVP & Chief Scienti ... | Sell | S | 7.59 | 36,709 | 278,621 | 0 | 36.7 K to 0 (-100.00 %) |
Dec 05 2011 | PRTK | Paratek Pharmaceut ... | Singh Nikhilesh N | SVP & Chief Scienti ... | Sell | S | 7.59 | 13,237 | 100,469 | 1,554 | 14.8 K to 1.6 K (-89.49 %) |
Dec 05 2011 | PRTK | Paratek Pharmaceut ... | Soloway Thomas P | SVP, Operations and ... | Option Exercise | M | 0.88 | 37,520 | 33,183 | 29,157 | |
Dec 05 2011 | PRTK | Paratek Pharmaceut ... | Soloway Thomas P | SVP, Operations and ... | Option Exercise | M | 2.68 | 25,150 | 67,402 | 38,750 | |
Dec 05 2011 | PRTK | Paratek Pharmaceut ... | Soloway Thomas P | SVP, Operations and ... | Sell | S | 8.57 | 37,520 | 321,438 | 0 | 37.5 K to 0 (-100.00 %) |
Dec 05 2011 | PRTK | Paratek Pharmaceut ... | Soloway Thomas P | SVP, Operations and ... | Buy | M | 0.88 | 37,520 | 33,183 | 37,520 | 0 to 37.5 K |
Dec 05 2011 | PRTK | Paratek Pharmaceut ... | Soloway Thomas P | SVP, Operations and ... | Sell | S | 8.23 | 25,150 | 207,047 | 0 | 25.2 K to 0 (-100.00 %) |